Surface oncology, inc. (SURF)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Cash flows from operating activities:
Net income (loss)

-28,020

-54,789

-43,570

-43,914

-42,008

-6,597

0

0

0

-

-

-

-

Net income (loss)

-

-

-

-

-

-

-

-

-

-

-

-

0

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization expense

1,812

1,785

1,689

1,570

1,456

1,347

1,289

1,217

1,127

964

0

0

0

Stock-based compensation expense

6,446

5,991

5,668

5,316

5,321

5,217

4,668

6,258

5,497

4,709

0

0

0

Non-cash interest expense related to note payable

0

-

-

-

-

-

-

-

-

-

-

-

-

Net amortization of premiums and discounts on marketable securities

618

764

836

819

635

377

98

-199

-422

-516

0

0

0

Realized losses on marketable securities

-

-

-

-

-

-

-

-

-

-2

0

0

0

Loss on disposal of property and equipment

0

-

-

-

-

-14

-13

-13

-13

-35

0

0

0

Non-cash operating lease cost

2,110

1,814

0

0

0

-

-

-

-

-

-

-

-

Deferred income tax benefit

-

-

-

-

-

-

-

-

-

-

0

0

0

Changes in operating assets and liabilities:
Amounts due from related party

-

-

-

-

-

-

-

-

-

-5,000

0

0

0

Prepaid expenses and other current assets

-1,480

-3,001

-2,034

-5,194

-2,634

-2,170

-3,330

-1,091

-2,717

-1,088

0

0

0

Other assets

117

-12

-33

-4

40

26

0

0

0

-

-

-

-

Accounts payable

-2,970

583

-2,275

-862

-2,768

23

367

940

934

285

0

0

0

Accrued expenses and other current liabilities

2,122

-710

1,139

988

1,830

-524

-1,536

484

-2,259

2,945

0

0

0

Deferred rent

-

-

-

-

-

52

121

218

125

-249

0

0

0

Operating lease liability

-1,487

-1,778

0

0

0

-

-

-

-

-

-

-

-

Other liabilities

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue - related party

-39,518

-15,360

-24,686

-26,073

-28,356

-14,417

0

0

0

-

-

-

-

Deferred revenue - related party

-

-

-

-

-

-

-

-

-

-

0

0

0

Net cash used in operating activities

-57,408

-60,140

-60,744

-58,497

-62,541

-13,222

0

0

0

-

-

-

-

Cash flows from investing activities:
Net cash provided by (used in) operating activities

-

-

-

-

-

-

-

-

-

-

-

-

0

Purchases of property and equipment

685

1,538

2,530

2,545

2,415

2,019

1,474

1,246

1,358

1,973

0

0

0

Purchases of marketable investments

48,696

118,347

0

0

0

-

-

-

-

-

-

-

-

Proceeds from sales or maturities of marketable securities

114,675

136,850

167,449

140,934

114,167

72,692

23,593

22,658

19,500

27,891

0

0

0

Net cash provided by (used in) investing activities

65,294

16,965

57,136

44,931

-65,806

-36,584

0

0

0

-

-

-

-

Cash flows from financing activities:
Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

0

Payments of initial public offering costs

-

-

-

-

-

2,031

0

0

0

-

-

-

-

Proceeds from issuance of common stock upon public offering, net

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from employee stock purchases

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

54

255

539

552

521

467

0

0

0

-

-

-

-

Net cash provided by financing activities

7,617

7,415

539

552

110,485

110,376

0

0

0

-

-

-

-

Net increase (decrease) in cash and cash equivalents and restricted cash

15,503

-35,760

-3,069

-13,014

-17,862

60,570

0

0

0

-

-

-

-

Net increase in cash and cash equivalents and restricted cash

-

-

-

-

-

-

-

-

-

-

0

0

0

Supplemental disclosure of cash flow information:
Cash paid for interest

0

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for income taxes

-

-

-

-

-

28

0

0

0

-

-

0

0

Supplemental disclosure of non-cash investing and financing activities:
Additional right-of-use asset and related lease liability

0

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

11

21

31

41

40

0

0

0

Deferred Offering costs included in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

0

-

-

-

-

Purchases of property and equipment included in accounts payable and accrued expenses

-

-

382

801

779

692

526

548

333

450

0

0

0

Reclassification of deposit liability for restricted stock upon vesting of shares

-

-

-

-

-

-

-

-

-

35

0

0

0

Landlord incentives for construction of leasehold improvements recorded as deferred rent

-

-

-

-

-

-

-

-

-

2,377

0

0

0